Feedback / Questions
olanzapine LAI (TEV-'749) - Teva, MedinCell
https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2025/Teva-Pharmaceuticals-Submits-New-Drug-Application-to-FDA-for-Olanzapine-Extended-Release-Injectable-Suspension-TEV-749-for-the-Once-Monthly-Treatment-of-Schizophrenia-in-Adults/default.aspx
Dec 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next